Postępowanie w subklinicznej niedoczynności tarczycy u dorosłych

• Authors: Rogala Natalia , Zdrojowy-Wełna Aleksandra , Zatońska Katarzyna , Bednarek-Tupikowska Grażyna
• Languages of publication: PL

Keywords

PL

subkliniczna hipotyreoza; leczenie subklinicznej niedoczynności tarczycy, L-tyroksyna, tyreotropina

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2015
• Issue: 1
• Pages: 55-59

Contributors

author

Rogala Natalia

author

Zdrojowy-Wełna Aleksandra

author

Zatońska Katarzyna

author

Bednarek-Tupikowska Grażyna

References

• Kuliczkowska-Płaksej J, Tupikowska M, Zatońska K, i wsp. Subkliniczna dysfunkcja tarczycy – czy i kiedy leczyć? Fam Med Prim Care Rev 2013; 15(1): 27–33.
• Pearce SHS, Brabant G, Duntas LH, et al. 2013 ET A Guidline: Management of subclinical hypothyroidism. Euro Thyr J 2013;2: 215–228.
• Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow up of the Wickham Survey. Clin Endocrinol 1995; 43: 55–68.
• Hollowell JG, Staehling NW , Flanders WD , et al. Serum TS H, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III ). J Clin Endocrinol Metab 2002; 87: 489–499.
• Canaris GJ, Manowitz NR , Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160:526–534.
• Garber JR , Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologist and the American Thyroid Association. Thyroid 2012; 22: 1200–1235.
• Huber G, Staub JJ , Meier C, et al. Prospective study of the spontaneous course of subclinical hupothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002; 87: 3221–3223.
• Stanicka S, Vondra K, Pelikanova T, et al. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and Turing thyroid hormone replacement therapy. Clin Chem Lab Med 2005; 43: 715–720.
• Wartofsky L, Dickey RA. Controversy in clinical endocrinology. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metabol 2005; 90: 5483–5488.
• Dayan CM, Saravanan P, Bayly G. Whose normal thyroid function is better – yours or mine? Lancet 2002; 360: 353–354.
• Surks MI, Goswami G, Daniels GH. Controversy in clinical endocrinology. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metabol 2005; 90: 5489–5496.
• Razvi S, Ingoe L, Keeka G, et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92: 1715–1723.
• Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005; 90: 4019–4024.
• Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292: 2591–2599
• Bednarek-Tupikowska G, Adamarczuk-Janczyszyn M., Rakowska-Chort A, et al. Utajona niedoczynność tarczycy. Pol Arch Med Wewn 2006; 116: 974–979.
• Taylor PN , Iqbal A, Minassian C, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from large community-based study. JAMA Intern Med 2014; 174: 32–39.
• Parle JV, Franklyn JA, Cross KW , et al. Thyroxine prescription in the community. Br J Gen Pract 1993; 43: 107–109.
• Turner MR, Camacho X, Fischer HD, et al. Levothyroxine dose and risk of fractures in older adults. BMJ 2011; 342: d2238.
• Flynn RW , Bonellie SR , Jung RT , et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab 2010; 95: 186–193.
• Cooper DS , Biondi B. Subclinical thyroid disease. Lancet 2012; 379: 1142–1154.
• Rozporządzenie Ministra Zdrowia z dnia 20.10.2014 r. zmieniające rozporządzenie w sprawie świadczeń gwarantowanych z zakresu podstawowej opieki zdrowotnej (Dz.U. z 2014 r., poz. 1440).